![[D-Tyr27,36,D-Thr32]- NeuropeptideY(27-36),rat;[D-Tyr27,36,D-Thr32]-NPY(27-36),rat <span class="caps">CAS</span> 163887-48-7](https://www.watson-int.com/wp-content/uploads/2025/03/no-image.png)
[D-Tyr27,36,D-Thr32]- NeuropeptideY(27-36),rat;[D-Tyr27,36,D-Thr32]-NPY(27-36),rat CAS 163887-48-7
[D-Tyr27,36,D-Thr32]-
NeuropeptideY(27-36),rat;[D-Tyr27,36,D-Thr32]-NPY(27-36),rat,163887-48-7,D-Tyr-Ile-Asn-Leu-Ile-D-Thr-
Arg-Gln-Arg-D-Tyr-NH2,C61H99N19O15




![Structure of (E)-2,2′-dibromo-4,4′-bis(2-ethylhexyl)-[6,6′-bithieno[3,2-b]pyrrolylidene]-5,5′(<span class="caps">4H</span>,<span class="caps">4H</span>’)-dione <span class="caps">CAS</span> 1147124-49-9 Structure of (E)-2,2'-dibromo-4,4'-bis(2-ethylhexyl)-[6,6'-bithieno[3,2-b]pyrrolylidene]-5,5'(4H,4H')-dione CAS 1147124-49-9](https://www.watson-int.com/wp-content/uploads/2018/06/Structure-of-E-22-dibromo-44-bis2-ethylhexyl-66-bithieno32-bpyrrolylidene-554H4H-dione-CAS-1147124-49-9.png)





